Niki BioSolutions, Inc. (NIKI) vs Exicure, Inc. (XCUR)

Niki BioSolutions, Inc. and Exicure, Inc. are both Biotechnology companies. Niki BioSolutions, Inc. and Exicure, Inc. are of similar size ($7.3M and $6.9M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against 42.6%. Exicure, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Exicure, Inc. leads on 8 and Niki BioSolutions, Inc. on 5.

Valuation

Metric NIKI XCUR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.26 9.71
P/B n/m 7.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.25 0.24 9.21
Earnings yield (330.05%) (118.92%) (33.15%)
Free cash flow yield 0.00% (84.13%) (25.50%)

Profitability

Metric NIKI XCUR Biotechnology median
Gross margin (87.96%) 80.08% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (921.74%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (168.37%) (56.36%)
Return on assets 0.00% (54.98%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NIKI XCUR Biotechnology median
Revenue growth (TTM) 42.64% 2,366.45% 6.02%
EPS growth (last fiscal year) 75.64% 83.37% 30.26%
Revenue growth, 5-year CAGR 2.38% 33.48% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NIKI XCUR Biotechnology median
Debt to equity 0.25 0.00 0.00
Current ratio 0.78 0.56 4.72
Net debt to EBITDA 0.02 0.99 0.96

Dividend

Metric NIKI XCUR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NIKI XCUR Biotechnology median
Market cap 6.92m 7.33m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack